Results
1452
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,452 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EH | US$12.21 | -1.7% | -43.7% | US$807.5m | US$24.98 | PS35.7x | E74.3% | n/a | Capital Goods | ||
VOW | NOK 7.64 | -1.9% | -54.2% | NOK 869.7m | NOK 11.00 | PB2.2x | E97.7% | 0% | Commercial Services | ||
GIG | NOK 30.15 | 1.7% | 9.6% | NOK 4.1b | NOK 45.03 | PE18.6x | E37.4% | n/a | Consumer Services | ||
KEBNI B | SEK 1.48 | -3.3% | -0.3% | SEK 401.9m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
505283 | ₹1,381.40 | 2.2% | 124.8% | ₹89.5b | ₹1,706.50 | PE62.9x | E30.1% | 0.5% | Capital Goods | ||
CUV | AU$14.68 | -2.0% | -16.7% | AU$735.1m | AU$30.33 | PE24.4x | E26.8% | 0.3% | Pharmaceuticals & Biotech | ||
A441270 | ₩7,840.00 | -2.0% | -5.5% | ₩289.9b | ₩11,500.00 | PE18.6x | E36.4% | n/a | Tech | ||
CALTX | SEK 206.20 | 0% | 111.5% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
688408 | CN¥59.86 | -11.9% | 24.5% | CN¥12.0b | CN¥66.22 | PE26.1x | E28.4% | 1.0% | Capital Goods | ||
4480 | JP¥3,650.00 | -10.5% | -27.3% | JP¥118.4b | JP¥5,800.00 | PE44.3x | E28.7% | n/a | Healthcare | ||
ACI | ₹771.45 | 5.3% | 49.6% | ₹95.2b | ₹788.17 | PE29.8x | E29.0% | 0.4% | Materials | ||
A137400 | ₩52,500.00 | -0.4% | -29.7% | ₩1.2t | ₩86,850.00 | PE14.1x | E35.0% | 0% | Capital Goods | ||
A067310 | ₩19,190.00 | 2.7% | -2.3% | ₩910.1b | ₩28,000.00 | PB3.1x | E97.4% | 0.3% | Semiconductors | ||
YGG | ฿1.31 | -1.5% | -83.4% | ฿788.6m | ฿10.75 | PE11.4x | E33.5% | 20.5% | Media | ||
A179900 | ₩29,700.00 | 0% | 51.5% | ₩469.9b | ₩60,000.00 | PS23.4x | E122.7% | 0% | Tech | ||
A178320 | ₩25,350.00 | -4.2% | 61.7% | ₩1.4t | ₩39,333.33 | PE131.9x | E58.7% | 0% | Tech | ||
PLT | AU$0.72 | 0% | 94.6% | AU$126.2m | AU$1.30 | PS1.8x | E106.4% | n/a | Diversified Financials | ||
ADOC | €6.08 | -5.3% | 5.9% | €91.4m | €6.30 | PS15.1x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
CTT | AU$1.31 | -5.8% | -54.4% | AU$535.4m | AU$3.12 | PE25.8x | E26.7% | n/a | Retail | ||
A204620 | ₩3,820.00 | -6.8% | -2.9% | ₩216.9b | ₩7,100.00 | PS2x | E72.4% | n/a | Commercial Services | ||
CRDO | US$25.33 | -11.4% | 54.0% | US$4.4b | US$32.17 | PS21.7x | E60.9% | n/a | Semiconductors | ||
BCS | NOK 5.40 | 24.9% | -39.9% | NOK 226.6m | NOK 9.00 | PS753x | E50.7% | n/a | Materials | ||
HQU | S$0.46 | -5.2% | 106.8% | S$65.1m | n/a | PE11.5x | E21.1% | 3.6% | Capital Goods | ||
6782 | NT$242.00 | -6.7% | 34.1% | NT$15.2b | NT$323.60 | PE35.2x | E33.5% | 1.0% | Healthcare |